Castle Biosciences (CSTL) Retained Earnings (2018 - 2026)
Castle Biosciences' (CSTL) quarterly Retained Earnings came in at -$238.8 million in Q1 2026, down 5.67% year-on-year from -$253.2 million in Q1 2025, and down 89540.45% quarter-over-quarter from $267000.0 in Q4 2025.
Castle Biosciences (CSTL) Retained Earnings (2018 - 2026) Analysis & Trends
Castle Biosciences has disclosed Retained Earnings across 9 years of filings, most recently posting -$238.8 million for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$238.8 million, down 5.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$238.8 million (down 5.67% YoY), and the FY2025 annual result was $267000.0, up 16.09% from the prior year.
- Retained Earnings came in at -$238.8 million for Q1 2026 at Castle Biosciences, down from $267000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $267000.0 in Q4 2025 to a low of -$238.8 million in Q1 2026.
- The 5-year median for Retained Earnings is -$160.9 million (2022), against an average of -$124.8 million.
- Peak annual rise in Retained Earnings reached 100.11% in 2025, while the deepest fall reached 203503.6% in 2025.
- Castle Biosciences' Retained Earnings stood at -$160.9 million in 2022, then soared by 100.08% to $136000.0 in 2023, then jumped by 69.12% to $230000.0 in 2024, then rose by 16.09% to $267000.0 in 2025, then sank by 89540.45% to -$238.8 million in 2026.
- The last three Retained Earnings figures came in at -$238.8 million (Q1 2026), $267000.0 (Q4 2025), and $240000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -168.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 60.63 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -593.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -64.94 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -202.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -2.86 Bn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -968.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -258.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -344.64 Mn |
| 10 | Castle Biosciences | 629.76 Mn | 368.04 Mn | 63.15 Mn | -238.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -238.81 Mn |
| Dec 31, 2025 | 267,000.00 |
| Sep 30, 2025 | 240,000.00 |
| Jun 30, 2025 | -221.45 Mn |
| Mar 31, 2025 | -226.00 Mn |
| Dec 31, 2024 | 230,000.00 |
| Sep 30, 2024 | -209.70 Mn |
| Jun 30, 2024 | -212.00 Mn |
| Mar 31, 2024 | -111,000.00 |
| Dec 31, 2023 | 136,000.00 |
| Sep 30, 2023 | -215.79 Mn |
| Jun 30, 2023 | -208.90 Mn |
| Mar 31, 2023 | -190.11 Mn |
| Dec 31, 2022 | -160.91 Mn |
| Sep 30, 2022 | -189,000.00 |
| Jun 30, 2022 | -120.04 Mn |
| Mar 31, 2022 | -118.39 Mn |
| Dec 31, 2021 | -93.77 Mn |
| Sep 30, 2021 | -87.36 Mn |
| Jun 30, 2021 | -75.57 Mn |